Search Results - "Hagan, Holly"

Refine Results
  1. 1

    Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews by Nelson, Paul K, MHSc, Mathers, Bradley M, MBChB, Cowie, Benjamin, PhD, Hagan, Holly, PhD, Des Jarlais, Don, Prof, Horyniak, Danielle, BBioMedSci, Degenhardt, Louisa, Prof

    Published in The Lancet (British edition) (13-08-2011)
    “…Summary Background Injecting drug use is an important risk factor for transmission of viral hepatitis, but detailed, transparent estimates of the scale of the…”
    Get full text
    Journal Article
  2. 2

    Differences in the fecal microbiota of neonates born at home or in the hospital by Combellick, Joan L., Shin, Hakdong, Shin, Dongjae, Cai, Yi, Hagan, Holly, Lacher, Corey, Lin, Din L., McCauley, Kathryn, Lynch, Susan V., Dominguez-Bello, Maria Gloria

    Published in Scientific reports (23-10-2018)
    “…Research on the neonatal microbiome has been performed mostly on hospital-born infants, who often undergo multiple birth-related interventions. Both the…”
    Get full text
    Journal Article
  3. 3

    On the way to Hepatitis C elimination in the Republic of Georgia-Barriers and facilitators for people who inject drugs for engaging in the treatment program: A formative qualitative study by Chikovani, Ivdity, Ompad, Danielle C, Uchaneishvili, Maia, Sulaberidze, Lela, Sikharulidze, Ketevan, Hagan, Holly, Van Devanter, Nancy L

    Published in PloS one (29-04-2019)
    “…Hepatitis C virus (HCV) infection is a significant public health concern worldwide. Georgia is among the countries with a high burden of HCV infection. People…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Racial and ethnic data justice: The urgency of surveillance data disaggregation by Gelpí-Acosta, Camila, Cano, Manuel, Hagan, Holly

    Published in Drug and alcohol dependence reports (01-09-2022)
    “…Disease and overdose surveillance across industrialized countries, including the United States (US), have historically relied upon racial and ethnic…”
    Get full text
    Journal Article
  6. 6

    Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment by Khan, Bilal, Duncan, Ian, Saad, Mohamad, Schaefer, Daniel, Jordan, Ashly, Smith, Daniel, Neaigus, Alan, Des Jarlais, Don, Hagan, Holly, Dombrowski, Kirk

    Published in PloS one (29-11-2018)
    “…Hepatitis C virus (HCV) infection is endemic in people who inject drugs (PWID), with prevalence estimates above 60% for PWID in the United States. Previous…”
    Get full text
    Journal Article
  7. 7

    High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review by Des Jarlais, Don C, Feelemyer, Jonathan P, Modi, Shilpa N, Abdul-Quader, Abu, Hagan, Holly

    Published in BMC public health (19-01-2013)
    “…Persons who inject drugs (PWID) are at an elevated risk for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infection. In many high-income…”
    Get full text
    Journal Article
  8. 8
  9. 9

    HSV-2 co-infection as a driver of HIV transmission among heterosexual non-injecting drug users in New York City by Des Jarlais, Don C, Arasteh, Kamyar, McKnight, Courtney, Perlman, David C, Feelemyer, Jonathan, Hagan, Holly, Cooper, Hannah L F

    Published in PloS one (31-01-2014)
    “…To examine herpes simplex virus 2 (HSV-2)/HIV co-infection as a contributing factor in the increase in HIV infection among non-injecting heroin and cocaine…”
    Get full text
    Journal Article
  10. 10

    Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data by Des Jarlais, Don C, Feelemyer, Jonathan P, Modi, Shilpa N, Arasteh, Kamyar, Mathers, Bradley M, Degenhardt, Louisa, Hagan, Holly

    Published in PloS one (01-03-2012)
    “…Injecting drug use continues to be a primary driver of HIV epidemics in many parts of the world. Many people who inject drugs (PWID) are sexually active, so it…”
    Get full text
    Journal Article
  11. 11

    Will "Combined Prevention" Eliminate Racial/Ethnic Disparities in HIV Infection among Persons Who Inject Drugs in New York City? by Des Jarlais, Don, Arasteh, Kamyar, McKnight, Courtney, Feelemyer, Jonathan, Hagan, Holly, Cooper, Hannah, Campbell, Aimee, Tross, Susan, Perlman, David

    Published in PloS one (12-05-2015)
    “…It has not been determined whether implementation of combined prevention programming for persons who inject drugs reduce racial/ethnic disparities in HIV…”
    Get full text
    Journal Article
  12. 12

    Patterns and Gaps Identified in a Systematic Review of the Hepatitis C Virus Care Continuum in Studies among People Who Use Drugs by Jordan, Ashly E, Perlman, David C, Reed, Jennifer, Smith, Daniel J, Hagan, Holly

    Published in Frontiers in public health (18-12-2017)
    “…Systematic reviews are useful for synthesizing data on various health conditions and for identifying gaps in available data. In the US, the main risk group for…”
    Get full text
    Journal Article
  13. 13

    Transitions from injecting to non-injecting drug use: Potential protection against HCV infection by Des Jarlais, Don C., Ph.D, McKnight, Courtney, M.P.H, Arasteh, Kamyar, Ph.D, Feelemyer, Jonathan, M.S, Perlman, David C., M.D, Hagan, Holly, Ph.D, Cooper, Hannah L.F., Sc.D

    Published in Journal of substance abuse treatment (01-03-2014)
    “…Abstract Transitions from injecting to non-injecting drug use have been reported from many different areas, particularly in areas with large human…”
    Get full text
    Journal Article
  14. 14

    HSV-2 Infection as a Cause of Female/Male and Racial/Ethnic Disparities in HIV Infection by Des Jarlais, Don C, Arasteh, Kamyar, McKnight, Courtney, Perlman, David C, Cooper, Hannah L F, Hagan, Holly

    Published in PloS one (18-06-2013)
    “…To examine the potential contribution of herpes simplex virus 2 (HSV-2) infection to female/male and racial/ethnic disparities in HIV among non-injecting…”
    Get full text
    Journal Article
  15. 15

    A Perfect Storm: Crack Cocaine, HSV-2, and HIV Among Non-Injecting Drug Users in New York City by Des Jarlais, Don C., McKnight, Courtney, Arasteh, Kamyar, Feelemyer, Jonathan, Perlman, David C., Hagan, Holly, Dauria, Emily F., Cooper, Hannah L.F.

    Published in Substance use & misuse (01-06-2014)
    “…Prevalence of human immunodeficiency virus (HIV) infection has reached 16% among non-injecting drug users (NIDU) in New York City, an unusually high prevalence…”
    Get full text
    Journal Article
  16. 16

    Experiences of Discrimination and HIV Risk Among Men Who Have Sex With Men in New York City by Reilly, Kathleen H., Neaigus, Alan, Jenness, Samuel M., Wendel, Travis, Marshall, David M., Hagan, Holly

    Published in American journal of men's health (01-11-2016)
    “…The extent of gay-related discrimination in New York City (NYC) and the demographic and behavioral factors correlated with experiences of gay-related…”
    Get full text
    Journal Article
  17. 17

    Positive deviance control-case life history: a method to develop grounded hypotheses about successful long-term avoidance of infection by Friedman, Samuel R, Mateu-Gelabert, Pedro, Sandoval, Milagros, Hagan, Holly, Des Jarlais, Don C

    Published in BMC public health (20-03-2008)
    “…Prevalence rates for long-term injection drug users in some localities surpass 60% for HIV and 80% for HCV. We describe methods for developing grounded…”
    Get full text
    Journal Article
  18. 18

    Sexual and injection-related risks in Puerto Rican-born injection drug users living in New York City: A mixed-methods analysis by Gelpí-Acosta, Camila, Hagan, Holly, Jenness, Samuel M, Wendel, Travis, Neaigus, Alan

    Published in Harm reduction journal (17-10-2011)
    “…These data were collected as part of the National HIV Behavioral Surveillance (NHBS) study. NHBS is a cross-sectional study to investigate HIV behavioral risks…”
    Get full text
    Journal Article
  19. 19

    Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services by Strauss, Shiela M, Astone-Twerell, Janetta, Munoz-Plaza, Corrine E, Des Jarlais, Don C, Gwadz, Marya, Hagan, Holly, Osborne, Andrew, Rosenblum, Andrew

    Published in BMC health services research (08-03-2007)
    “…In spite of the disproportionate prevalence of hepatitis C virus (HCV) infection among drug users, many remain uninformed or misinformed about the virus. Drug…”
    Get full text
    Journal Article
  20. 20

    Exploring Barriers and Facilitators to Integrating a Harm Reduction Approach to Substance Use in Three Medical Settings by Lindenfeld, Zoe, Hagan, Holly, Chang, Ji Eun

    “…Background Evidence suggests that harm reduction, a public health strategy aimed at reducing the negative consequences of a risky health behavior without…”
    Get full text
    Journal Article